Medical industry in Jiading grows amid crisis

The medical equipment and precision medical industry in Jiading maintained growth for two consecutive months, with output reaching 1.07 billion yuan (US$151 million) in the first quarter, up 25.9 percent year on year.

In the first quarter, the output of bio-related industry reached 1.91 billion yuan, an increase of 18 percent. Official data highlighted the urgent demand for medical products amid the COVID-19 outbreak, which promoted the development of the industry.

Jiading-based Shanghai New Sky Bio-tech Co provided 2 million nucleic acid detection reagent components for Wuhan, former epicenter of the outbreak. Its neighbor, Shanghai Taitool Bioscience Co, began developing a vaccine.

In the Yucheng biotechnology park in Jiading Industrial Zone, many biotech startups have found opportunities during the novel coronavirus crisis.

Diding, a biotech firm in the park, developed a sampling tube for inactivated viruses. The Yuying Photoelectricity produced 50 flat panel detectors.

Jiading has proposed the acceleration of the construction of a cluster of precision medicine and health services, trying to build an industrial chain worth 100 billion yuan and create a world-class precision medicine industry.

An industrial park for precision medicine in Nanxiang Town has attracted nearly 70 professional institutions and companies to launch their businesses.

At present, Nanxiang is making every effort to industrialize precision medicine. In the future, in its core research and development base, the industrial park will see a high ground of global precision medicine industrialization.

It will also become a transformation center for precision medicine innovation, a cluster of innovators and a distribution center of innovation factors.

The park also plans to build a manufacturing base through the establishment of standard workshops which will be in operation in the next five years.